谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Global regulatory agencies support the use of dopamine transporter neuroimaging for subject selection in clinical trials targeting early stage parkinson's disease - on behalf of critical path for Parkinson's (CPP) Consortium

D. Stephenson,J. Cedarbaum,J. Eberling,M. Facheris,D. Grosset, M. Gordon,D. Hill, S. Imam,V. Kern, G. Klein, D. Matthews,P. Muglia,A. Roach,K. Romero,D. Russell,J. Seibyl, L. Slieker,E. Somer,C. Sur, Z. Xie,K. Marek

MOVEMENT DISORDERS（2017）

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要